Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Cariprazine in Major Depressive Disorder
NCT01838876Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Apr 2013
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of cariprazine in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Apr 2013; status: completed.
02
Drugs
cariprazine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01838876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838876.